Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accumulated Expenses: 2022

Historic Accumulated Expenses for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to $6.4 million.

  • Lexeo Therapeutics' Accumulated Expenses was N/A to $11.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $11.8 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Lexeo Therapeutics reported Accumulated Expenses of $6.4 million as of FY2022.
  • Lexeo Therapeutics' Accumulated Expenses' 5-year high stood at $6.4 million during FY2022, with a 5-year trough of $6.4 million in FY2022.
  • Moreover, its 1-year median value for Accumulated Expenses was $6.4 million (2022), whereas its average is $6.4 million.